Mednet Logo
HomeGynecologic OncologyQuestion

Would you consider HIPEC in patients with advanced ovarian cancer undergoing primary cytoreductive surgery?

1 Answers
Mednet Member
Mednet Member
Gynecologic Oncology · University of California, Los Angeles

HIPEC is hyperthermic intraperitoneal chemotherapy and is often administered as a onetime dose after cytoreductive surgery. HIPEC has been clinically used in malignancies that can impact the peritoneal surfaces. For the following two reasons I do not administer HIPEC during surgery for patients unde...

Register or Sign In to see full answer

Would you consider HIPEC in patients with advanced ovarian cancer undergoing primary cytoreductive surgery? | Mednet